Literature DB >> 33127745

A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.

Francisco Díez-Fuertes1,2, María Iglesias-Caballero3, Javier García-Pérez4, José Alcamí4,2, Inmaculada Casas5, Sara Monzón6, Pilar Jiménez7, Sarai Varona6, Isabel Cuesta6, Ángel Zaballos7, Mercedes Jiménez7, Laura Checa4, Francisco Pozo3, Mayte Pérez-Olmeda4, Michael M Thomson8.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole-genome analysis has identified five large clades worldwide which emerged in 2019 (19A and 19B) and in 2020 (20A, 20B, and 20C). This study aimed to analyze the diffusion of SARS-CoV-2 in Spain using maximum-likelihood phylogenetic and Bayesian phylodynamic analyses. The most recent common ancestor (MRCA) of the SARS-CoV-2 pandemic was estimated to have emerged in Wuhan, China, around 24 November 2019. Phylogenetic analyses of the first 12,511 SARS-CoV-2 whole-genome sequences obtained worldwide, including 290 from 11 different regions of Spain, revealed 62 independent introductions of the virus in the country. Most sequences from Spain were distributed in clades characterized by a D614G substitution in the S gene (20A, 20B, and 20C) and an L84S substitution in ORF8 (19B) with 163 and 118 sequences, respectively, with the remaining sequences branching in 19A. A total of 110 (38%) sequences from Spain grouped in four different monophyletic clusters of clade 20A (20A-Sp1 and 20A-Sp2) and 19B clade (19B-Sp1 and 19B-Sp2) along with sequences from 29 countries worldwide. The MRCAs of clusters 19A-Sp1, 20A-Sp1, 19A-Sp2, and 20A-Sp2 were estimated to have occurred in Spain around 21 and 29 January and 6 and 17 February 2020, respectively. The prevalence of clade 19B in Spain (40%) was by far higher than in any other European country during the first weeks of the epidemic, probably as a result of a founder effect. However, this variant was replaced by G614-bearing viruses in April. In vitro assays showed an enhanced infectivity of pseudotyped virions displaying the G614 substitution compared with those having D614, suggesting a fitness advantage of D614G.IMPORTANCE Multiple SARS-CoV-2 introductions have been detected in Spain, and at least four resulted in the emergence of locally transmitted clusters that originated not later than mid-February, with further dissemination to many other countries around the world, and a few weeks before the explosion of COVID-19 cases detected in Spain during the first week of March. The majority of the earliest variants detected in Spain branched in the clade 19B (D614 viruses), which was the most prevalent clade during the first weeks of March, pointing to a founder effect. However, from mid-March to June 2020, G614-bearing viruses (clades 20A, 20B, and 20C) overcame D614 variants in Spain, probably as a consequence of an evolutionary advantage of this substitution in the spike protein. A higher infectivity of G614-bearing viruses than D614 variants was detected, suggesting that this substitution in SARS-CoV-2 spike protein could be behind the variant shift observed in Spain.
Copyright © 2021 Díez-Fuertes et al.

Entities:  

Keywords:  COVID-19; Europe; SARS-CoV-2; Spain; phylodynamics; phylogeography

Year:  2021        PMID: 33127745     DOI: 10.1128/JVI.01583-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; África Holguín
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

2.  SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations.

Authors:  Brenda Martínez-González; María Eugenia Soria; Lucía Vázquez-Sirvent; Cristina Ferrer-Orta; Rebeca Lobo-Vega; Pablo Mínguez; Lorena de la Fuente; Carlos Llorens; Beatriz Soriano; Ricardo Ramos-Ruíz; Marta Cortón; Rosario López-Rodríguez; Carlos García-Crespo; Pilar Somovilla; Antoni Durán-Pastor; Isabel Gallego; Ana Isabel de Ávila; Soledad Delgado; Federico Morán; Cecilio López-Galíndez; Jordi Gómez; Luis Enjuanes; Llanos Salar-Vidal; Mario Esteban-Muñoz; Jaime Esteban; Ricardo Fernández-Roblas; Ignacio Gadea; Carmen Ayuso; Javier Ruíz-Hornillos; Nuria Verdaguer; Esteban Domingo; Celia Perales
Journal:  Pathogens       Date:  2022-06-08

Review 3.  Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic.

Authors:  Stephen W Attwood; Sarah C Hill; David M Aanensen; Thomas R Connor; Oliver G Pybus
Journal:  Nat Rev Genet       Date:  2022-04-22       Impact factor: 59.581

4.  Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador.

Authors:  Bernardo Gutierrez; Sully Márquez; Belén Prado-Vivar; Mónica Becerra-Wong; Juan José Guadalupe; Darlan da Silva Candido; Juan Carlos Fernandez-Cadena; Gabriel Morey-Leon; Rubén Armas-Gonzalez; Derly Madeleiny Andrade-Molina; Alfredo Bruno; Domenica de Mora; Maritza Olmedo; Denisse Portugal; Manuel Gonzalez; Alberto Orlando; Jan Felix Drexler; Andres Moreira-Soto; Anna-Lena Sander; Sebastian Brünink; Arne Kühne; Leandro Patiño; Andrés Carrazco-Montalvo; Orson Mestanza; Jeannete Zurita; Gabriela Sevillano; Louis du Plessis; John T McCrone; Josefina Coloma; Gabriel Trueba; Verónica Barragán; Patricio Rojas-Silva; Michelle Grunauer; Moritz U G Kraemer; Nuno R Faria; Marina Escalera-Zamudio; Oliver G Pybus; Paúl Cárdenas
Journal:  medRxiv       Date:  2021-04-05

5.  Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.

Authors:  Lorena Vigón; Daniel Fuertes; Javier García-Pérez; Montserrat Torres; Sara Rodríguez-Mora; Elena Mateos; Magdalena Corona; Adolfo J Saez-Marín; Rosa Malo; Cristina Navarro; María Aranzazu Murciano-Antón; Miguel Cervero; José Alcamí; Valentín García-Gutiérrez; Vicente Planelles; María Rosa López-Huertas; Mayte Coiras
Journal:  Front Immunol       Date:  2021-05-26       Impact factor: 7.561

6.  Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.

Authors:  Malik Sallam; Azmi Mahafzah
Journal:  Pathogens       Date:  2021-03-05

7.  Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador.

Authors:  Bernardo Gutierrez; Sully Márquez; Belén Prado-Vivar; Mónica Becerra-Wong; Juan José Guadalupe; Darlan Da Silva Candido; Juan Carlos Fernandez-Cadena; Gabriel Morey-Leon; Rubén Armas-Gonzalez; Derly Madeleiny Andrade-Molina; Alfredo Bruno; Domenica De Mora; Maritza Olmedo; Denisse Portugal; Manuel Gonzalez; Alberto Orlando; Jan Felix Drexler; Andres Moreira-Soto; Anna-Lena Sander; Sebastian Brünink; Arne Kühne; Leandro Patiño; Andrés Carrazco-Montalvo; Orson Mestanza; Jeannete Zurita; Gabriela Sevillano; Louis Du Plessis; John T McCrone; Josefina Coloma; Gabriel Trueba; Verónica Barragán; Patricio Rojas-Silva; Michelle Grunauer; Moritz U G Kraemer; Nuno R Faria; Marina Escalera-Zamudio; Oliver G Pybus; Paúl Cárdenas
Journal:  Virus Evol       Date:  2021-06-04

8.  Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.

Authors:  Benjamin Trinité; Edwards Pradenas; Silvia Marfil; Carla Rovirosa; Víctor Urrea; Ferran Tarrés-Freixas; Raquel Ortiz; Jordi Rodon; Júlia Vergara-Alert; Joaquim Segalés; Victor Guallar; Rosalba Lepore; Nuria Izquierdo-Useros; Glòria Trujillo; Jaume Trapé; Carolina González-Fernández; Antonia Flor; Rafel Pérez-Vidal; Ruth Toledo; Anna Chamorro; Roger Paredes; Ignacio Blanco; Eulàlia Grau; Marta Massanella; Jorge Carrillo; Bonaventura Clotet; Julià Blanco
Journal:  Viruses       Date:  2021-06-12       Impact factor: 5.048

9.  Sequencing of SARS-CoV-2 genome using different nanopore chemistries.

Authors:  Oscar González-Recio; Mónica Gutiérrez-Rivas; Ramón Peiró-Pastor; Pilar Aguilera-Sepúlveda; Cristina Cano-Gómez; Miguel Ángel Jiménez-Clavero; Jovita Fernández-Pinero
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-01       Impact factor: 4.813

Review 10.  The virological impacts of SARS-CoV-2 D614G mutation.

Authors:  Chenxi Wang; You Zheng; Zubiao Niu; Xiaoyi Jiang; Qiang Sun
Journal:  J Mol Cell Biol       Date:  2021-12-30       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.